Two Sigma Advisers’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $220K | Sell |
15,700
-55,100
| -78% | -$773K | ﹤0.01% | 2087 |
|
|
2025
Q1 | $1.11M | Buy |
+70,800
| New | +$1.11M | ﹤0.01% | 1429 |
|
|
2024
Q4 | – | Sell |
-182,800
| Closed | -$1.7M | – | 2337 |
|
|
2024
Q3 | $1.7M | Sell |
182,800
-305,800
| -63% | -$2.84M | ﹤0.01% | 1156 |
|
|
2024
Q2 | $4.54M | Buy |
488,600
+157,700
| +48% | +$1.47M | 0.01% | 801 |
|
|
2024
Q1 | $3.28M | Buy |
+330,900
| New | +$3.28M | 0.01% | 961 |
|
|
2023
Q2 | – | Sell |
-16,000
| Closed | -$176K | – | 2381 |
|
|
2023
Q1 | $176K | Sell |
16,000
-119,600
| -88% | -$1.32M | ﹤0.01% | 2287 |
|
|
2022
Q4 | $2.01M | Buy |
135,600
+64,400
| +90% | +$953K | 0.01% | 1249 |
|
|
2022
Q3 | $1.36M | Buy |
+71,200
| New | +$1.36M | ﹤0.01% | 1373 |
|
|
2021
Q4 | – | Sell |
-27,700
| Closed | -$662K | – | 2614 |
|
|
2021
Q3 | $662K | Sell |
27,700
-34,200
| -55% | -$817K | ﹤0.01% | 1806 |
|
|
2021
Q2 | $1.69M | Sell |
61,900
-15,700
| -20% | -$428K | ﹤0.01% | 1376 |
|
|
2021
Q1 | $2.25M | Buy |
77,600
+48,300
| +165% | +$1.4M | 0.01% | 1207 |
|
|
2020
Q4 | $824K | Buy |
+29,300
| New | +$824K | ﹤0.01% | 1659 |
|